cholesteryl myristate

(3beta)-cholest-5-en-3-yl tetradecanoate

CAS: 1989-52-2 C41 H72 O2 MW: 597.02324000

Identification

Namecholesteryl myristate
CAS Number1989-52-2
EINECS217-867-8
FDA UNIISearch
Molecular FormulaC41 H72 O2
Molecular Weight597.02324000
MDL NumberMFCD00307644
Nikkaji NumberJ151.217J

Regulatory

Physical Properties

Assay 95.00 to 100.00
Food Chemicals Codex Listed No
Boiling Point 630.67 °C. @ 760.00 mm Hg (est)
Flash Point 635.00 °F. TCC ( 334.80 °C. ) (est)
logP (o/w) 16.656 (est)
Soluble in water, 7.438e-012 mg/L @ 25 °C (est)

No sensory data available

Safety Information

Preferred SDSView
Oral/Parenteral ToxicityNot determined
Dermal ToxicityNot determined
Inhalation ToxicityNot determined

GHS Classification

['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']

Safety in Use

Categoryinformation only not used for fragrances or flavors
Recommendation for cholesteryl myristate usage levels up tonot for fragrance use.
Recommendation for cholesteryl myristate flavor usage levels up tonot for flavor use.

BOC Sciences

Best of Chemicals Supplier

Quality supplier of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecul...

View All Website 1-631-485-4226 account@bocsci.com

Potential Uses

None Found

Natural Occurrence

not found in nature

Synonyms

(3b)- cholest-5-en-3-yl myristate (3beta)- cholest-5-en-3-yl tetradecanoate cholest-5-en-3beta-yl myristate cholesterol 1-tetradecanoate cholesterol myristate cholesterol, myristate (8CI) cholesteryl tetradecanoate cholestryl myristate [(3S,8S,9S,10R,13R,14S,17R)-10,13- dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] tetradecanoate tetradecanoic acid, (3b)-cholest-5-en-3-yl ester PubMed: Chemical stability of phospholipid-stabilized supercooled smectic cholesteryl myristate nanoparticles. PubMed: PEGylation of supercooled smectic cholesteryl myristate nanoparticles. PubMed: The physical state of lipid nanoparticles influences their effect on in vitro cell viability. PubMed: Cholesterol myristate suppresses the apoptosis of mesenchymal stem cells via upregulation of inhibitor of differentiation. PubMed: Influence of stabilizer systems on the properties and phase behavior of supercooled smectic nanoparticles. PubMed: The serum fatty acids myristic acid and linoleic acid are better predictors of serum cholesterol concentrations when measured as molecular percentages rather than as absolute concentrations. PubMed: Autocrine BMP4 signaling involves effect of cholesterol myristate on proliferation of mesenchymal stem cells. PubMed: Calculation of the T-X phase diagrams for binary mixtures of cholestanyl myristate-cholesteryl myristate and cholestanyl myristate-cholesteryl oleate. PubMed: Effect of lysozyme adsorption on the interfacial rheology of DPPC and cholesteryl myristate films. PubMed: [Studies on chemical constituents of marine bryozoan Bugula neritina L]. PubMed: Influence of preparation conditions and heat treatment on the properties of supercooled smectic cholesteryl myristate nanoparticles. PubMed: Serum fatty acids as biomarkers of fat intake predict serum cholesterol concentrations in a population-based survey of New Zealand adolescents and adults. PubMed: Novel cholesterol esterase secreted by Streptomyces persists during aqueous long-term storage. PubMed: Viscosity peaks at the cholesteric-isotropic phase transitions. PubMed: Crystallization behavior of supercooled smectic cholesteryl myristate nanoparticles containing phospholipids as stabilizers. PubMed: Supercooled smectic nanoparticles: a potential novel carrier system for poorly water soluble drugs. PubMed: Analysis of adrenal cholesteryl esters by reversed phase high performance liquid chromatography. PubMed: Molecular organization and motions of cholesteryl esters in crystalline and liquid crystalline phases: a 13C and 1H magic angle spinning NMR study. PubMed: Crystal structure of cholestanyl caprylate and binary phase behavior with cholesteryl caprylate. PubMed: Cholesteryl esters of saturated fatty acids: cosolubility and fractionation of binary mixtures. PubMed: Thermotropic mesomorphism of cholesteryl myristate. An electron diffraction study. PubMed: Structure of the cholesteryl ester core of human plasma low density lipoproteins: selective deuteration and neutron small-angle scattering. PubMed: Cholesteryl myristate conformation in liquid crystalline mesophases determined by neutron scattering. PubMed: Interactions of cholesterol esters with phospholipids: cholesteryl myristate and dimyristoyl lecithin. PubMed: Structure of human plasma low-density lipoproteins: molecular organization of the central core. PubMed: Thermal stability of biological lipids. I. Differential scanning calorimetry of mixtures of cholesteryl myristate and cholesteryl palmitate. PubMed: Light scattering and microscopic investigations of mesophase transitions of cholesteryl myristate. II. Kinetics of spherulite formation. PubMed: Light scattering and microscopic investigations of mesophase transition of cholesteryl myristate. I. Morphology of the cholesteric phase.